Brief: Galera Reports Fourth Quarter And 2022 Financial Results
March 8 (Reuters) - Galera Therapeutics Inc GRTX.O :
* GALERA REPORTS FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL
RESULTS AND RECENT CORPORATE UPDATES
* Q4 LOSS PER SHARE $0.58
* AS OF DECEMBER 31, 2022, GALERA HAD CASH, CASH EQUIVALENTS
AND
SHORT-TERM INVESTMENTS OF $31.6 MILLION
* Q4 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX6MJH18
Further company coverage: GRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Galera Therapeutics
See all newsBrief: Galera Therapeutics Says Nasdaq Will Delist Co's Common Stock By Filing Form 25 With SEC On Sept 4
Brief: Galera Announces Board Approval Of Complete Liquidation And Dissolution
Brief: Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares
Brief: Alpha Pharma Investments Llc Reports 10.899% Passive Stake In Galera Therapeutics
Brief: Galera Adopts Limited Duration Stockholder Rights Agreement